Synovial Sarcoma, X Breakpoint 2B (SSX2B) (AA 21-70) antibody
-
- Target See all Synovial Sarcoma, X Breakpoint 2B (SSX2B) Antibodies
- Synovial Sarcoma, X Breakpoint 2B (SSX2B)
-
Binding Specificity
- AA 21-70
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- Un-conjugated
-
Application
- Western Blotting (WB)
- Specificity
- Human SSX2B
- Purification
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa21-70 of human SSX2B (Q16385-2). Percent identity by BLAST analysis: Human (100%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product SSX2B Primary Antibody
-
anti-Synovial Sarcoma, X Breakpoint 2B (SSX2B) (C-Term) antibody
SSX2B Reactivity: Human WB, ELISA, IHC (p) Host: Rabbit Polyclonal unconjugated
anti-Synovial Sarcoma, X Breakpoint 2B (SSX2B) (N-Term) antibodySSX2B Reactivity: Human, Dog, Mouse, Pig WB Host: Rabbit Polyclonal unconjugated
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Distilled water
- Concentration
- Lot specific
- Buffer
- Lyophilized from PBS, 2 % sucrose.
- Storage
- 4 °C,-20 °C
- Storage Comment
-
Short term: 4°C
Long term: -20°C.
-
- Target
- Synovial Sarcoma, X Breakpoint 2B (SSX2B)
- Alternative Name
- SSX2B (SSX2B Products)
- Background
-
Name/Gene ID: SSX2B
Synonyms: SSX2B
-
